November 21, 2024 Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in developing GLP-1 injectables BRIDGEWATER,
Ready-to-Use Products from Amneal Allow You to Focus on What Matters Most A US-based company with strong roots in generic pharmaceuticals, Amneal is growing its
The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the
August 20, 2024 Propofol is an essential surgical anesthetic in hospitals that is in chronic shortage Complex emulsion injectable expands Amneal’s injectables portfolio BRIDGEWATER, N.J.–(BUSINESS
NACDS Total Store Expo 2024 August 17 – 19, 2024 | Boston, MA Discover new and innovative products, technology and services and find the partners
August 7, 2024 Delivers more “Good On” time with less frequent dosing compared to Immediate Release CD/LD Underscores Amneal’s leadership in Parkinson’s disease and commitment to
With consistent supply, proven quality and reliable service, Amneal is in the bag business for the long haul. We’re committed to providing the institutional market
With consistent supply, proven quality and reliable service, Amneal is in the bag business for the long haul. We’re committed to providing the institutional market
